Angiostatin Inhibits Endothelial and Melanoma Cellular Invasion by Blocking Matrix-Enhanced Plasminogen Activation

Biochemical Journal - United Kingdom
doi 10.1042/0264-6021:3400077
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

Soluble M6p/Igf2r Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2011English

Activation of Vav/Rho GTPase Signaling by CXCL12 Controls Membrane-Type Matrix Metalloproteinase–Dependent Melanoma Cell Invasion

Cancer Research
Cancer ResearchOncology
2006English

Control of Melanoma Morphogenesis, Endothelial Survival, and Perfusion by Extracellular Matrix

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2002English

Regulation of Plasminogen Activation by TGF-beta in Cultured Human Retinal Endothelial Cells

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Endothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking P38 MAPK Activation

PLoS ONE
Multidisciplinary
2016English

Genistein Inhibits P38 Map Kinase Activation, Matrix Metalloproteinase Type 2, and Cell Invasion in Human Prostate Epithelial Cells

Cancer Research
Cancer ResearchOncology
2005English

microRNA-125b Inhibits Cell Migration and Invasion by Targeting Matrix Metallopeptidase 13 in Bladder Cancer

Oncology Letters
Cancer ResearchOncology
2013English

3,4-Methylenedioxy-Β-Nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

17-Aag Inhibits Vemurafenib-Associated MAP Kinase Activation and Is Synergistic With Cellular Immunotherapy in a Murine Melanoma Model

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy